References
- Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932–946. doi: 10.1183/09031936.04.00014304.
- Fromer L. Diagnosing and treating COPD: understanding the challenges and finding solutions. Int J Gen Med. 2011;4:729–739. doi: 10.2147/IJGM.S21387.
- European Respiratory Society. European Lung White Book. [cited 2017 July 4]. Available from: https://www.erswhitebook.org/chapters/the-economic-burden-of-lung-disease/.
- Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2006 revision [cited 2017 July 4]. Available from: http://www.who.int/respiratory/copd/GOLD_WR_06.pdf.
- Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2011 revision [cited 2017 July 4]. Available from: http://www.goldcopd.org/.
- Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2017 revision [cited 2017 July 4]. Available from: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/.
- Nowak M, Brozek GM, Zejda JE, Jankowski M, Pierzchała W. Impact of changing GOLD guidelines (2007–2011–2017) on assignment of a COPD patient to disease severity category. Adv Dermatol Allergol. 2018 [cited 2017 July 4]; [1–8]. doi: 10.5114/ada.2018.79143.
- Iannella H, Luna C, Waterer G. Inhaled corticosteroids and the increased risk of pneumonia: what’s new? A 2015 updated review. Ther Adv Resp Dis. 2016;10(3):235–255. doi: 10.1177/1753465816630208.
- Marçôa R, Rodrigues DM, Dias M, et al. Classification of chronic obstructive pulmonary disease (COPD) according to the new Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017: comparison with GOLD 2011. COPD. 2018;15(1):21–26. doi: 10.1080/15412555.2017.1394285.
- Maio S, Baldacci S, Martini F, et al. COPD management according to old and new GOLD guidelines: an observational study with Italian general practitioners. Curr Med Res Opin. 2014;30(6):1033–1042. doi: 10.1185/03007995.2014.884492.
- Nowak M, Jankowski M, Brożek GM, et al. Profile of adults suffering from COPD in Poland. Wiad Lek. 2017;70(1):9–15.
- Glaab T, Banik N, Rutschmann OT, Wencker M. National survey of guideline-compliant COPD management among pneumologists and primary care physicians. COPD. 2006;3(3):141–148. doi: 10.1080/15412550600829299.
- Suissa S, Barnes PJ. Inhaled corticosteroids in COPD: the case against. Eur Respir J. 2009;34(1):13–16. doi: 10.1183/09031936.00190908.
- Roberts CM, Lopez-Campos JL, Hartl S. The European COPD Audit: brothers in arms. Breathe. 2012;8:267–270. doi: 10.1183/20734735.012812.
- Moreira S, Oliveira C, Escaleira D, et al. The impact of the three GOLD severity classifications of COPD (2001, 2011 and 2017) in the same population of the patients. Paper presented at: ERS International Congress 2017; Milan, Italy; 2017 Sept 9–13.
- Mathioudakis A, Vestbo J, Gayle A, et al. Estimating potential cost savings associated with managing COPD according to GOLD 2017 recommendations in UK primary care: a CPRD study. Paper presented at: ERS International Congress 2018; 2018 Sept 15–19; Paris, France.
- Sin DD, Miravitlles M, Mannino DM, et al. What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion. Eur Respir J. 2016;48(3):664–673. doi: 10.1183/13993003.00436-2016.
- Miravitlles M, Vogelmeier C, Roche N, et al. A review of national guidelines for management of COPD in Europe. Eur Respir J. 2016;47(2):625–637. doi: 10.1183/13993003.01170-2015.